DOI: 10.12890/2022_003606

Pulmonary Arterial Hypertension Associated With Primary Sjögren’s Syndrome: An Unusual Association

Authors

  • Pedro Ribeirinho-Soares Internal Medicine Department, University Hospital Center of São João, Porto, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal
  • Estela Sousa Internal Medicine Department, University Hospital Center of São João, Porto, Portugal
  • Inês Silva Internal Medicine Department, University Hospital Center of São João, Porto, Portugal
  • Jorge Almeida Internal Medicine Department, University Hospital Center of São João, Porto, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal

jpedroarsoares@gmail.com

Keywords

Primary Sjögren’s syndrome, pulmonary artery hypertension

Abstract

Pulmonary arterial hypertension (PAH) is an increasingly recognised clinical entity that is associated with connective tissue disease (CTD) in up to one quarter of all diagnoses. Sjögren’s syndrome (SS) is a chronic autoimmune disease characterised by ocular and oral dryness resulting from lacrimal and salivary gland dysfunction. Additionally, SS may involve virtually any organ system and, as a result, the disease is characterised by pleomorphic clinical manifestations. However, SS-PAH reports are scarce, and the area remains insufficiently studied. We present a case of a 75-year-old female with a new diagnosis of PAH and SS.

View the entire article

Downloads

References

  1. Wang J, Li M, Wang Q, Zhang X, Qian J, Zhao J, et al.Pulmonary arterial hypertension associated with primary Sjogren’s syndrome: a multi-centre cohort study from China. Eur Clin Respir J 2020;1902157.
  2. Benza RL, Miller DP, Bars RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from the time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest 2012;142:448-56.
  3. Kylhammar D, Kjellstrom B, Hjalmarsson C, Jansson K, Nissel M, Söderberg S, et al. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Eur Heart J 2018;39:4175-4181.
  4. Negrin S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, et al. Sjögren’s syndrome: a systemic autoimmune disease. Clin Exp Med 2022;22:9-25.
  5. Kokosi M, Riemer EC, Highland KB. Pulmonary involvement in Sjögren syndrome. Clin Chest Med. 2010;31:489-500.
  6. Hwang JA, Yan TH, Lee JY, Koo DW, Choi IS, Cho SY, et al. Severe pulmonary hypertension in primary Sjögren’s syndrome. Korean Circ J. 2013;43:504-507.
  7. Kobak S, Kalkan S, Kirilmaz B, Orman M, Ercan E. Pulmonary arterial hypertension in patients with primary Sjögren’s syndrome. Autoimmune Dis. 2014;710401.
  8. Sakiyama T, Hirai I, Konohana A, Takae Y. Interstitial-type granuloma annulare associated with Sjögren syndrome. J Dtsch Dermatol Ges. 2014;12:415-416.
  9. Sumikawa Y, Ansai S, Kimura T, Nakamura J, Inui S, Katayama I. Interstitial type granuloma annulare associated with Sjögren’s syndrome. J Dermatol. 2010;37:493-5.
  10. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;00:1-114.
  11. Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, et al. Guidelines for the treatment of pulmonary hypertension. Circ J. 2019;83:842-945.
  12. Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. [Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 2007; 86:299-315.

Published

2022-11-10

Issue

Vol. 9 No. 11 (2022)

How to Cite

1.
Ribeirinho-Soares P, Sousa E, Silva I, Almeida J. Pulmonary Arterial Hypertension Associated With Primary Sjögren’s Syndrome: An Unusual Association. EJCRIM [Internet]. 2022 Nov. 10 [cited 2026 Nov. 3];9(11). Available from: https://ejcrim.com/index.php/ejcrim/article/view/3606

Most read articles by the same author(s)

1 2 > >>